Dashboard
Poor long term growth as Operating profit has grown by an annual rate -13.10% of over the last 5 years
The company has declared Negative results for the last 6 consecutive quarters
With ROE of 3.3, it has a Very Expensive valuation with a 1.6 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,770 Cr (Small Cap)
39.00
42
0.91%
-0.16
3.56%
1.56
Total Returns (Price + Dividend) 
Latest dividend: 1.4856215213358073 per share ex-dividend date: Jul-24-2026
Risk Adjusted Returns v/s 
Returns Beta
News
NOCIL consolidated net profit rises 60.83% in the June 2026 quarter
NOCIL consolidated net profit rises 60.83% in the June 2026 quarter Business Standard...
Read More Announcements 
Board Meeting Intimation for Board Meeting Intimation For Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2026
05-Oct-2026 | Source : BSENOCIL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results for the quarter and half yearly ended on 30th September 2026
Closure of Trading Window
23-Sep-2026 | Source : BSETrading Window shall be closed from Wednesday 30th September 2026 for the designated and connected persons till the conclusion of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarterly and half yearly ended on 30th September 2026.
Grant Of Options Under Long Term Incentive Plan-2024 (Performance Restricted Stock Units(Prsus))
23-Sep-2026 | Source : BSEGrant of Options Under Long term Incentive Plan -2024 (Performance Restricted Stock Units(PRSUs))
Corporate Actions 
29 Oct 2026
NOCIL Ltd has declared 15% dividend, ex-date: 24 Jul 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
21.2613
Held by 7 Schemes (6.69%)
Held by 57 FIIs (4.78%)
Hrishikesh Arvind Mafatlal (as A Trustee Of Gurukripa Trust) (18.16%)
Mahindra Manulife Small Cap Fund (3.57%)
43.9%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 22.00% vs 4.59% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 63.29% vs 83.78% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.63% vs -3.23% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -52.94% vs -10.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.44% vs -3.60% in Mar 2025
YoY Growth in year ended Mar 2026 is -45.92% vs -22.66% in Mar 2025